AVY
74
6
PFE
19
-6
HSY
41
-2
BF.B
51
-2
HBAN
51
-2
MCD
50
-12
TROW
48
-3
HPE
16
2
FITB
58
-2
TGT
59
-3
FLS
50
-3
SHW
45
-11
GOOG
79
-4
MAT
50
-5
CTAS
53
4
PNW
48
-11
AON
32
-4
GME
60
2
CINF
50
-3
MSI
57
3
AVY
74
6
PFE
19
-6
HSY
41
-2
BF.B
51
-2
HBAN
51
-2
MCD
50
-12
TROW
48
-3
HPE
16
2
FITB
58
-2
TGT
59
-3
FLS
50
-3
SHW
45
-11
GOOG
79
-4
MAT
50
-5
CTAS
53
4
PNW
48
-11
AON
32
-4
GME
60
2
CINF
50
-3
MSI
57
3
Financhill
Back

ProQR Therapeutics NV Quote, Financials, Valuation and Earnings

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
38

PRQR
ProQR Therapeutics NV

Last Price:
1.95
Seasonality Move:
1.68%

7 Day Trial

ALL ACCESS PASS

$ 7

I love this overnight trade happening Thursday

Access my free presentation on these overnight trades right here

ProQR Therapeutics NV Price Quote

$1.95
-0.01 (-0.51%)
(Updated: April 26, 2024 at 6:55 PM ET)

ProQR Therapeutics NV Key Stats

Sell
38
ProQR Therapeutics NV (PRQR) is a Sell
Day range:
$1.84 - $2.03
52-week range:
$1.11 - $3.29
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
22.54
P/B ratio:
3.49%
Volume:
202K
Avg. volume:
175.3K
1-year change:
-11.71%
Market cap:
$159.5M
Revenue:
$7.1M
EPS:
$-0.38

How Much Does ProQR Therapeutics NV Make?

Is ProQR Therapeutics NV Growing As A Company?

  • What Is ProQR Therapeutics NV's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.8%
  • What Is ProQR Therapeutics NV's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ProQR Therapeutics NV Stock Price Performance

What Is ProQR Therapeutics NV 52-Week High & Low?

ProQR Therapeutics NV Price To Free Cash Flow

Is It Risky To Buy ProQR Therapeutics NV?

Is ProQR Therapeutics NV Cash Flow Positive?

  • What Is PRQR Cash Flow From Operations?
    Cash flow from operations (TTM) is $23.3M
  • What Is ProQR Therapeutics NV’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2.5M
  • What Is ProQR Therapeutics NV’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $4.6M

ProQR Therapeutics NV Return On Invested Capital

  • Is Management Doing A Good Job?
    PRQR return on invested capital is -47.86%
  • What Is ProQR Therapeutics NV Return On Assets?
    ROA measures how assets are converting to revenues and is -18.57%
  • What Is PRQR Return On Equity?
    ROE is a measure of profitability and is -53.15%

ProQR Therapeutics NV Earnings Date & Stock Price

ProQR Therapeutics NV Competitors

ProQR Therapeutics NV Dividend Yield

Data Unavailable

ProQR Therapeutics NV Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 33.54%
Revenue: 380.37% -57.33%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.10
Upside from Last Price: 109.18%

Major Shareholders

  • How many PRQR shares are owned by institutional investors?
    28.4M PRQR shares are owned by institutional investors
  • How many PRQR shares are owned by insiders?
    74.5M PRQR shares are owned by insiders